- Home
- FNWB vs WHWK Comparison
FNWB vs WHWK Comparison
Compare FNWB & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWB
- WHWK
- Stock Information
- Founded
- FNWB 1923
- WHWK 2007
- Country
- FNWB United States
- WHWK United States
- Employees
- FNWB N/A
- WHWK N/A
- Industry
- FNWB Banks
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- FNWB Finance
- WHWK Health Care
- Exchange
- FNWB Nasdaq
- WHWK Nasdaq
- Market Cap
- FNWB 79.5M
- WHWK 87.6M
- IPO Year
- FNWB 2015
- WHWK N/A
- Fundamental
- Price
- FNWB $7.73
- WHWK $1.95
- Analyst Decision
- FNWB Hold
- WHWK
- Analyst Count
- FNWB 1
- WHWK 0
- Target Price
- FNWB $12.00
- WHWK N/A
- AVG Volume (30 Days)
- FNWB 12.8K
- WHWK 117.3K
- Earning Date
- FNWB 07-24-2025
- WHWK 08-15-2025
- Dividend Yield
- FNWB 3.58%
- WHWK N/A
- EPS Growth
- FNWB N/A
- WHWK N/A
- EPS
- FNWB N/A
- WHWK 0.91
- Revenue
- FNWB $49,473,000.00
- WHWK $27,775,000.00
- Revenue This Year
- FNWB $38.07
- WHWK $49.83
- Revenue Next Year
- FNWB $13.28
- WHWK N/A
- P/E Ratio
- FNWB N/A
- WHWK $2.13
- Revenue Growth
- FNWB N/A
- WHWK 16.51
- 52 Week Low
- FNWB $6.05
- WHWK $1.21
- 52 Week High
- FNWB $12.10
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- FNWB 43.20
- WHWK N/A
- Support Level
- FNWB $7.68
- WHWK N/A
- Resistance Level
- FNWB $8.02
- WHWK N/A
- Average True Range (ATR)
- FNWB 0.27
- WHWK 0.00
- MACD
- FNWB 0.02
- WHWK 0.00
- Stochastic Oscillator
- FNWB 5.49
- WHWK 0.00
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.